Zoetis (ZTS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Zacks Zacksで開く
Zoetis (ZTS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zoetis (ZTS) reported $2.26 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 1.9%. EPS of $1.53 for the same period compares to $1.48 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $2.3 billion, representing a surprise of -1.66%. The company delivered an EPS surprise of -5.09%, with the consensus EPS estimate being $1.61.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Zoetis performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Geographic Revenues- U.S.: $1.09 billion versus $1.2 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -7.9% change. Geographic Revenues- International Revenue: $1.15 billion versus the four-analyst average estimate of $1.08 billion. The reported number represents a year-over-year change of +14%. Geographic Revenues- International- Companion Animal: $654 million versus $609.45 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +14.1% change. Geographic Revenues- U.S.- Livestock: $225 million versus the three-analyst average estimate of $221.92 million. The reported number represents a year-over-year change of +7.1%. Geographic Revenues- International- Livestock: $495 million versus the three-analyst average estimate of $465.47 million. The reported number represents a year-over-year change of +13.8%. Revenues- Contract Manufacturing & Human Health: $23 million versus the four-analyst average estimate of $28.94 million. The reported number represents a year-over-year change of -20.7%. Revenues- Companion Animal: $1.52 billion versus $1.58 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -1.8% change. Revenues- Livestock: $720 million versus $680.48 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +11.6% change. Revenues- Livestock- Swine: $123 million compared to the $112.11 million average estimate based on two analysts. The reported number represents a change of +10.8% year over year. Revenues- Livestock- Cattle: $392 million versus the two-analyst average estimate of $370.52 million. The reported number represents a year-over-year change of +9.5%. Revenues- Livestock- Fish: $66 million versus the two-analyst average estimate of $57 million. The reported number represents a year-over-year change of +24.5%. Revenues- Livestock- Poultry: $118 million compared to the $110.22 million average estimate based on two analysts. The reported number represents a change of +11.3% year over year.

View all Key Company Metrics for Zoetis here>>>

Shares of Zoetis have returned -7.1% over the past month versus the Zacks S&P 500 composite's +11.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Beyond Nvidia: AI's Second Wave Is Here

The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.

See Stocks Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Zoetis Inc. (ZTS): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research